Goldman Sachs: Maintaining the Singular Genomics Sys (OMIC.US) rating, adjusted from neutral to neutral, and adjusted the target price from $0.85 to $0.75.
高盛：维持Singular Genomics Sys(OMIC.US)评级，由中性调整至中性评级, 目标价由0.85美元调整至0.75美元。
Goldman Sachs: Maintaining the Singular Genomics Sys (OMIC.US) rating, adjusted from neutral to neutral, and adjusted the target price from $0.85 to $0.75.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.